Shin-Ichiro Miyashita

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Clinical Evaluation

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shin-Ichiro Miyashita, Shura Karatsu, Mako Fujiishi, I Hsun Huang, Yuki Nagashima, Tamaki Morobishi, Keita Hosoya, Tsuyoshi Hata, Min Dong, Yoshimasa Sagane
Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A. Toxins 15 (2) (2023)
Shin-Ichiro Miyashita, Shura Karatsu, Mako Fujiishi, I Hsun Huang, Yuki Nagashima, Tamaki Morobishi, Keita Hosoya, Tsuyoshi Hata, Min Dong, Yoshimasa Sagane
Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A. Toxins 15 (2) (2023)
Shin-Ichiro Miyashita, Shura Karatsu, Mako Fujiishi, I Hsun Huang, Yuki Nagashima, Tamaki Morobishi, Keita Hosoya, Tsuyoshi Hata, Min Dong, Yoshimasa Sagane
Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A. Toxins 15 (2) (2023)
Shin-Ichiro Miyashita, Shura Karatsu, Mako Fujiishi, I Hsun Huang, Yuki Nagashima, Tamaki Morobishi, Keita Hosoya, Tsuyoshi Hata, Min Dong, Yoshimasa Sagane
Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A. Toxins 15 (2) (2023)
Shin-Ichiro Miyashita, Shura Karatsu, Mako Fujiishi, I Hsun Huang, Yuki Nagashima, Tamaki Morobishi, Keita Hosoya, Tsuyoshi Hata, Min Dong, Yoshimasa Sagane
Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A. Toxins 15 (2) (2023)
Shin-Ichiro Miyashita, Shura Karatsu, Mako Fujiishi, I Hsun Huang, Yuki Nagashima, Tamaki Morobishi, Keita Hosoya, Tsuyoshi Hata, Min Dong, Yoshimasa Sagane
Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A. Toxins 15 (2) (2023)
Shin-Ichiro Miyashita, Jie Zhang, Sicai Zhang, Charles B Shoemaker, Min Dong
Delivery of single-domain antibodies into neurons using a chimeric toxin-based platform is therapeutic in mouse models of botulism. Science translational medicine 13 (575) (2021)
Hatim Thaker, Jie Zhang, Shin-Ichiro Miyashita, Vivian Cristofaro, SunHyun Park, Ali Hashemi Gheinani, Maryrose P Sullivan, Rosalyn M Adam, Min Dong
Knockin mouse models demonstrate differential contributions of synaptotagmin-1 and -2 as receptors for botulinum neurotoxins. PLoS pathogens 17 (10) (2021)